Ehsan Amini-Salehi, Sandeep Samethadka Nayak, Gautam Maddineni, Abinash Mahapatro, Mohammad-Hossein Keivanlou, Saman Soltani Moghadam, Azin Vakilpour, Maryam Sadat Aleali, Farahnaz Joukar, Mohammad Hashemi, Naeim Norouzi, Arash Bakhshi, Ali Bahrampourian, Fariborz Mansour-Ghanaei, Soheil Hassanipour
BACKGROUND AND AIM: Modulating the gut microbiota population by administration of probiotics, prebiotics, and synbiotics has shown to have a variety of health benefits in different populations, particularly those with metabolic disorders. Although the promising effects of these compounds have been observed in the management of patients with non-alcoholic fatty liver disease (NAFLD), the exact effects and the mechanisms of action are yet to be understood. In the present study, we aimed to evaluate how gut microbiota modulation affects anthropometric indices of NAFLD patients to achieve a comprehensive summary of current evidence-based knowledge...
May 2024: Annals of Medicine and Surgery